| abstract |
1. N- (4- (7-Azabicyclo [2.2.1] heptan-7-yl) -2- (trifluoromethyl) phenyl) -4-oxo-5- (trifluoromethyl) -1,4-dihydroquinoline-3-carboxamide characterized as form A-HCl. 2. Form A-HCl according to claim 1, where the form A-HCl is characterized by one or more peaks in the X-ray powder diffraction pattern selected from the group comprising a peak of about 7.1 degrees, a peak of about 21.2 degrees, a peak in the region of about 6.9 to about 7.3 degrees, a peak in the region from about 8.0 to about 8.4 degrees, a peak in the region from about 13.9 to about 14.3 degrees, a peak in the region from about 21.0 to about 21.4 degrees, peak in the region from about 14.5 to about 14.9 degrees, peak in the region from about 16.2 to about 16.6 degrees, peak in the region from about 1 8.5 to about 18.9 degrees and a peak in the region of about 22.6 to about 23.0 degrees. 3. Form A-HCl according to claim 1 or 2, where form A-HCl is characterized by a peak in the region from about 6.9 to about 7.3 degrees, a peak in the region from about 8.0 to about 8.4 degrees, a peak in the region from about 13.9 to about 14.3 degrees and a peak in the region from about 21.0 to about 21.4 degrees in the X-ray powder diffraction pattern. Form A-HCl according to claim 1, where form A-HCl is characterized by one or more peaks in the C NMR spectrum selected from the group comprising a peak of about 163.7 ppm, a peak of about 137.2 ppm. and a peak of about 121.5 ppm. 5. Form A-HCl according to claim 4, where the form A-HCl is characterized by a peak of about 163.7 ppm, a peak of about 137.2 ppm. and a peak of about 121.5 ppm cC NMR spectrum. 6. Form A-HCl according to claim 1, where form A-HCl is characterized by one or more peaks in the F NMR spectrum selected from the group comprising a peak of about -57.0 ppm and a peak of about -60.5 m D 7. Form A-HCl according to claim 1, where form A-HCl is characterized by a single crystal, which |